Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Eneuro|July 21, 2019
Sphingomyelin in Brain and Cognitive Development: Preliminary DataNora Schneider, Jonas Hauser, Manuel Oliveira, et al.
Human Psychopharmacology|November 1, 2007
The cognitive effects of modulating the glycine site of the NMDA receptor with high-dose glycine in healthy controlsColin Palmer, Kathryn A Ellis, Barry V O'Neill, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 8, 2006
Acute serotonin and dopamine depletion improves attentional control: findings from the stroop taskKirsty E Scholes, Ben J Harrison, Barry V O'Neill, et al.
European Journal of Sport Science|June 30, 2022
Effect of intensified training on cognitive function, psychological state & performance in trained cyclistsSarah E Costello, Jack R W Rossiter, Glyn Howatson, et al.
Appetite|August 18, 2012
The relationship between fat mass, eating behaviour and obesity-related psychological traits in overweight and obese individualsBarry V O'Neill, Edward T Bullmore, Sam Miller, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 27, 2007
Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and p50 suppression measures of sensorimotor and sensory gating in humansCollette Mann, Rodney J Croft, Kirsty E Scholes, et al.
Frontiers in Nutrition|March 4, 2022
A Nutrient Formulation Affects Developmental Myelination in Term Infants: A Randomized Clinical TrialNora Schneider, Muriel M K Bruchhage, Barry V O'Neill, et al.
Human Psychopharmacology|May 25, 2019
The effects of GSK2981710, a medium-chain triglyceride, on cognitive function in healthy older participants: A randomised, placebo-controlled studyBarry V O'Neill, Chris M Dodds, Sam R Miller, et al.
The International Journal of Neuropsychopharmacology|July 13, 2011
The effects of the dopamine D₃ receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjectsPradeep J Nathan, Barry V O'Neill, Karin Mogg, et al.
Journal of Clinical Pharmacology|December 14, 2011
Multiple-dose safety, pharmacokinetics, and pharmacodynamics of the μ-opioid receptor inverse agonist GSK1521498Pradeep J Nathan, Mark A Bush, Wenli X Tao, et al.
Pageof 4